In breast cancer, overexpression of PRMT1 promotes tumor metastasis by modulating EZH2 [23], and PRMT1 is associated with and prompts insulin-like growth factor I signaling in ER-positive breast cancer cells [24]. The gene discussed is PRMT1; the disease is breast carcinoma.